Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CETP | P11597 | 1/20 | 0.51 |
| ▸ | SELP | P16109 | 6/20 | 0.43 |
| ▸ | SELL | P14151 | 5/20 | 0.43 |
| ▸ | SELE | P16581 | 3/20 | 0.43 |
| ▸ | APP | P05067 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | VEGFA | P15692 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8333761 | 0.79 | SELL (0.59) | CETPSELPSELLSELEAPP | |
| SCHEMBL8334049 | 0.79 | SELL (0.59) | CETPSELPSELLSELEAPP | |
| SCHEMBL15618389 | 0.79 | SELL (0.59) | CETPSELPSELLSELEAPP | |
| SCHEMBL1573005 | 0.79 | SELL (0.59) | CETPSELPSELLSELEAPP | |
| SCHEMBL15618579 | 0.79 | SELL (0.59) | CETPSELPSELLSELEAPP | |
| SCHEMBL8334043 | 0.79 | SELL (0.59) | CETPSELPSELLSELEAPP | |
| SCHEMBL15618321 | 0.79 | SELL (0.59) | CETPSELPSELLSELEAPP | |
| SCHEMBL8333751 | 0.79 | SELL (0.59) | CETPSELPSELLSELEAPP | |
| SCHEMBL15618387 | 0.79 | SELL (0.59) | CETPSELPSELLSELEAPP | |
| SCHEMBL15618578 | 0.79 | SELL (0.59) | CETPSELPSELLSELEAPP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120082728-A1 | MULTIFUNCTIONAL STEALTH NANOPARTICULES FOR BIOMEDICAL USE | UNIVERSITE DE STRASBOURG (FR) | 2012-04-05 | — | — | US | claimed |
| US-20120082728-A1 | MULTIFUNCTIONAL STEALTH NANOPARTICULES FOR BIOMEDICAL USE | UNIVERSITE DE STRASBOURG (FR) | 2012-04-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120082728-A1 | MULTIFUNCTIONAL STEALTH NANOPARTICULES FOR BIOMEDICAL USE | EPHA2, CD47, MSN | CETP 575/4885SELP 25/4885SELL 414/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.